BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19076229)

  • 1. Identification of new inhibitors for alternative NADH dehydrogenase (NDH-II).
    Mogi T; Matsushita K; Murase Y; Kawahara K; Miyoshi H; Ui H; Shiomi K; Omura S; Kita K
    FEMS Microbiol Lett; 2009 Feb; 291(2):157-61. PubMed ID: 19076229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dehydrogenases in the aerobic respiratory chain of the rodent malaria parasite Plasmodium yoelii yoelii.
    Kawahara K; Mogi T; Tanaka TQ; Hata M; Miyoshi H; Kita K
    J Biochem; 2009 Feb; 145(2):229-37. PubMed ID: 19060309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin B identified as an inhibitor of alternative NADH dehydrogenase and malate: quinone oxidoreductase from the Gram-positive bacterium Mycobacterium smegmatis.
    Mogi T; Murase Y; Mori M; Shiomi K; Omura S; Paranagama MP; Kita K
    J Biochem; 2009 Oct; 146(4):491-9. PubMed ID: 19564154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Auxiliary NADH Dehydrogenase Plays a Crucial Role in Redox Homeostasis of Nicotinamide Cofactors in the Absence of the Periplasmic Oxidation System in Gluconobacter oxydans NBRC3293.
    Sriherfyna FH; Matsutani M; Hirano K; Koike H; Kataoka N; Yamashita T; Nakamaru-Ogiso E; Matsushita K; Yakushi T
    Appl Environ Microbiol; 2021 Jan; 87(2):. PubMed ID: 33127815
    [No Abstract]   [Full Text] [Related]  

  • 5. The consequence of an additional NADH dehydrogenase paralog on the growth of Gluconobacter oxydans DSM3504.
    Kostner D; Luchterhand B; Junker A; Volland S; Daniel R; Büchs J; Liebl W; Ehrenreich A
    Appl Microbiol Biotechnol; 2015 Jan; 99(1):375-86. PubMed ID: 25267158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agrobacterium tumefaciens type II NADH dehydrogenase. Characterization and interactions with bacterial and thylakoid membranes.
    Bernard L; Desplats C; Mus F; Cuiné S; Cournac L; Peltier G
    FEBS J; 2006 Aug; 273(15):3625-37. PubMed ID: 16884501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Tethering' fragment-based drug discovery to identify inhibitors of the essential respiratory membrane protein type II NADH dehydrogenase.
    Heikal A; Nakatani Y; Jiao W; Wilson C; Rennison D; Weimar MR; Parker EJ; Brimble MA; Cook GM
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2239-2243. PubMed ID: 29859905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myricetin Acts as an Inhibitor of Type II NADH Dehydrogenase from
    Zhou JL; Chen HH; Xu J; Huang MY; Wang JF; Shen HJ; Shen SX; Gao CX; Qian CD
    Molecules; 2024 May; 29(10):. PubMed ID: 38792214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three families of respiratory NADH dehydrogenases.
    Kerscher S; Dröse S; Zickermann V; Brandt U
    Results Probl Cell Differ; 2008; 45():185-222. PubMed ID: 17514372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The origin of the sodium-dependent NADH oxidation by the respiratory chain of Klebsiella pneumoniae.
    Bertsova YV; Bogachev AV
    FEBS Lett; 2004 Apr; 563(1-3):207-12. PubMed ID: 15063750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 NADH Dehydrogenase Is the Only Point of Entry for Electrons into the Streptococcus agalactiae Respiratory Chain and Is a Potential Drug Target.
    Lencina AM; Franza T; Sullivan MJ; Ulett GC; Ipe DS; Gaudu P; Gennis RB; Schurig-Briccio LA
    mBio; 2018 Jul; 9(4):. PubMed ID: 29970468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the bacterial type II NADH dehydrogenase: a monotopic membrane protein with an essential role in energy generation.
    Heikal A; Nakatani Y; Dunn E; Weimar MR; Day CL; Baker EN; Lott JS; Sazanov LA; Cook GM
    Mol Microbiol; 2014 Mar; 91(5):950-64. PubMed ID: 24444429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphipathic C-terminal region of Escherichia coli NADH dehydrogenase-2 mediates membrane localization.
    Villegas JM; Volentini SI; Rintoul MR; Rapisarda VA
    Arch Biochem Biophys; 2011 Jan; 505(2):155-9. PubMed ID: 20933494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of substrate specificity in single point mutants of Agrobacterium tumefaciens type II NADH dehydrogenase.
    Desplats C; Beyly A; Cuiné S; Bernard L; Cournac L; Peltier G
    FEBS Lett; 2007 Aug; 581(21):4017-22. PubMed ID: 17673203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.
    Sellamuthu S; Singh M; Kumar A; Singh SK
    Expert Opin Ther Targets; 2017 Jun; 21(6):559-570. PubMed ID: 28472892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global motion affecting electron transfer in Plasmodium falciparum type II NADH dehydrogenases: a novel non-competitive mechanism for quinoline ketone derivative inhibitors.
    Xie T; Wu Z; Gu J; Guo R; Yan X; Duan H; Liu X; Liu W; Liang L; Wan H; Luo Y; Tang D; Shi H; Hu J
    Phys Chem Chem Phys; 2019 Aug; 21(33):18105-18118. PubMed ID: 31396604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization.
    Murugesan D; Ray PC; Bayliss T; Prosser GA; Harrison JR; Green K; Soares de Melo C; Feng TS; Street LJ; Chibale K; Warner DF; Mizrahi V; Epemolu O; Scullion P; Ellis L; Riley J; Shishikura Y; Ferguson L; Osuna-Cabello M; Read KD; Green SR; Lamprecht DA; Finin PM; Steyn AJC; Ioerger TR; Sacchettini J; Rhee KY; Arora K; Barry CE; Wyatt PG; Boshoff HIM
    ACS Infect Dis; 2018 Jun; 4(6):954-969. PubMed ID: 29522317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cu(II)-reductase NADH dehydrogenase-2 of Escherichia coli improves the bacterial growth in extreme copper concentrations and increases the resistance to the damage caused by copper and hydroperoxide.
    Rodríguez-Montelongo L; Volentini SI; Farías RN; Massa EM; Rapisarda VA
    Arch Biochem Biophys; 2006 Jul; 451(1):1-7. PubMed ID: 16759635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines.
    Schurig-Briccio LA; Yano T; Rubin H; Gennis RB
    Biochim Biophys Acta; 2014 Jul; 1837(7):954-63. PubMed ID: 24709059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel promoter gHp0169 for gene expression in Gluconobacter oxydans.
    Shi L; Li K; Zhang H; Liu X; Lin J; Wei D
    J Biotechnol; 2014 Apr; 175():69-74. PubMed ID: 24530540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.